BioSET Overview

  • Year Founded
  • 2001

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 9

Employees

  • Latest Deal Type
  • M&A

BioSET General Information

Description

Developer of synthetic bioactive peptides. The company develops synthetic peptides used for bone growth and tissue regeneration in the treatment of musculoskeletal, vascular and chronic wound diseases.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 9430 Key West Avenue
  • Suite 220
  • Rockville, MD 20850
  • United States
+1 (301)
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Acquirer
Corporate Office
  • 9430 Key West Avenue
  • Suite 220
  • Rockville, MD 20850
  • United States
+1 (301)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BioSET Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 16-Feb-2015 Completed Clinical Trials - Phase 3
4. Later Stage VC (Series D) 10-May-2011 Completed Clinical Trials - Phase 3
3. Later Stage VC (Series C) 11-Jun-2007 Completed Clinical Trials - Phase 3
2. Early Stage VC (Series B) 30-Sep-2004 $5.74M $8.66M Completed Startup
1. Early Stage VC (Series A) 25-Feb-2002 $2.92M $2.92M Completed Startup
To view BioSET’s complete valuation and funding history, request access »

BioSET Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series D
Series C
Series B 9,900,000 $0.001000 $0.05 $0.58 $0.58 1x $0.43 17.29%
Series A 3,893,607 $0.001000 $0.06 $0.75 $0.75 1x $0.48 7.93%
To view BioSET’s complete cap table history, request access »

BioSET Patents

BioSET Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-2046350-A2 Composition and method for delivery of bmp-2 amplifier/co-activator for enhancement of osteogenesis Inactive 22-Jun-2006
EP-2046350-A4 Composition and method for delivery of bmp-2 amplifier/co-activator for enhancement of osteogenesis Inactive 22-Jun-2006
WO-2007150053-A2 Composition and method for delivery of bmp-2 amplifier/co-activator for enhancement of osteogenesis Inactive 22-Jun-2006
WO-2007150053-A3 Composition and method for delivery of bmp-2 amplifier/co-activator for enhancement of osteogenesis Inactive 22-Jun-2006
WO-2007150053-B1 Composition and method for delivery of bmp-2 amplifier/co-activator for enhancement of osteogenesis Inactive 22-Jun-2006 C07K14/4705
To view BioSET’s complete patent history, request access »

BioSET Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

BioSET Former Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
Alloy Ventures Venture Capital Minority
EDF Ventures Venture Capital Minority
Heron Capital Venture Capital Minority
InnerDyne Corporation Minority
MB Venture Partners Venture Capital Minority
You’re viewing 5 of 10 investors. Get the full list »

BioSET FAQs

  • When was BioSET founded?

    BioSET was founded in 2001.

  • Where is BioSET headquartered?

    BioSET is headquartered in Rockville, MD.

  • What is the size of BioSET?

    BioSET has 9 total employees.

  • What industry is BioSET in?

    BioSET’s primary industry is Biotechnology.

  • Is BioSET a private or public company?

    BioSET is a Private company.

  • What is BioSET’s current revenue?

    The current revenue for BioSET is .

  • How much funding has BioSET raised over time?

    BioSET has raised $26.3M.

  • Who are BioSET’s investors?

    Alloy Ventures, EDF Ventures, Heron Capital, InnerDyne, and MB Venture Partners are 5 of 10 investors who have invested in BioSET.

  • When was BioSET acquired?

    BioSET was acquired on 16-Feb-2015.

  • Who acquired BioSET?

    BioSET was acquired by Ferring.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process